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Abstract 
Background: This study reports a case of Prader Willi syndrome (PWS), a genomic imprinting disease related to 
chromosome regions 15q11.2–q13 15, which includes hypothalamic dysfunction leading to hyperphagia, obesity, 
shortness, sleep abnormalities. Our case is extremely severe, in comparison to other PWS cases described in literature, 
due to the association with severe emotional and psychiatric symptoms: oppositional behaviour, rigidity of thought, 
skin picking and pathological hoarding.
Case presentation: We described the case of a Caucasian male patient suffering from PWS, treated in outpatient 
care by local Mental Health Centre and supported by Social Service, who was admitted to a residential rehabilita-
tive facility. After a 2-year follow-up, the patient showed a global improvement in symptoms and functioning, 
as registered by the rating scales administered. At the end of observation period, we also reported an important 
improvement in weight control, reducing the risk of obesity and related diseases, therefore improving the progno-
sis of life.
Conclusion: This case highlights the need for long-term, individualized and multi-professional treatment in patients 
suffering from a complex genetic syndrome with both organic and psychological alterations, for which medical care 
setting and pharmacological treatments are not sufficient. Clinical observation of this case leads us to compare PWS 
to drug addiction and indirectly endorse the neurophysiological hypothesis that food and drugs stimulate the same 
brain circuits in the limbic system.
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Background
Genetics and diagnosis
Prader-Willi syndrome (PWS), described for the first 
time in 1956 by the Swiss doctors from which it takes 
its name, presents a prevalence ranging from 1:10,000 
to 1:30,000. It is present in both males and females of all 
races and is rarely inherited (only one person in a family 
is usually affected by this syndrome) [1].
PWS, the first human disorder to be recognized as 
related to genomic imprinting, is caused by the failure of 
expression of paternal genes presented in the region of 
chromosome 15q11.2–q13 15 [2, 3]. The main molecular 
mechanisms responsible for PWS are [4]:
Paternal microdeletion (75–80  % of cases); maternal 
disomy (UPD) (20–25 % of cases); imprinting defect (ID), 
(1–3  % of cases); other defects, such as balanced and 
unbalanced translocations, which with ID are responsible 
for most cases of familial inherited PWS.
A set of clinical criteria was proposed by Gunay-
Aygun and collaborators [5] in order to identify the 
subjects which required an appropriate genetic test to 
diagnose PWS: poor muscle tone, reduced ability to suck 
milk and, if male, cryptorchidism in early childhood 
and delay in neurological developmental, short stature, 
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psychomotor retardation, obsessive behaviour, compul-
sive ingestion of food with obesity in middle childhood 
and adolescence.
PWS diagnosis requires the execution of a test called 
DNA methylation (specific multiplex ligation-dependent 
probe amplification analysis, abbreviated MS-MLPA).
Endocrinological, cognitive and behavioural alterations
Most endocrine disorders in PSW are secondary to hypo-
thalamic dysfunction [6], which is responsible for the 
deficiency of growth hormone, thyroid stimulating hor-
mone, adrenal-corticoid hormones and hypogonadism [4, 
7]. The reduced secretion of gonadotropins and growth 
hormone condition neonatal hypotonia, short stature, 
puberty failure, as well as all the behavioural manifesta-
tions that are associated with this syndrome. Central 
hypothyroidism, with a normal value of thyroid stimulat-
ing hormone and low levels of free thyroxine, has been 
documented in approximately 25  % of individuals with 
PWS [1]. Other key symptoms, such as hyperphagia and 
altered control of appetite [8], alteration of sleep-wake 
cycle [6], dysfunction of body temperature regulation [9] 
and increased pain threshold [10] would be secondary to 
alterations in hypothalamic function [8]. Obesity in PWS 
is mainly central (abdomen, buttocks and thighs) in both 
sexes, with a reduced amount of visceral fat compared to 
other patients with the same degree of overweight [11]. 
Several studies have shown that ghrelin levels are sig-
nificantly elevated before and after meals in hyperphagic 
individuals with PWS, especially in older children and 
in adults. In children with PWS has been found hyper-
ghrelinemy [12], but this result has not been replicated in 
other studies [13, 14]. Some authors have examined the 
neural circuit that mediates appetite and eating behav-
iour (orbitofrontal cortex and hypothalamus) and have 
shown, through functional magnetic resonance imaging, 
that this circuit in PWS is abnormally activated during 
the intake of high-caloric food [15, 16]. Reduced sleep 
latency rapid eye movement (REM) with altered architec-
ture of the different stages of sleep, oxygen desaturation 
and obstructive apnea have been reported in PWS [17].
A literature review of cognitive abilities among 575 
individuals affected by PWS showed that only 5  % of 
these patients had a normal IQ [4]. 70–90 % of patients 
with PWS present behavioural disorders since childhood, 
characterized by impaired impulse control with bursts 
of anger, manipulative attitudes [4], and compulsions, in 
particular pathological hoarding (especially food) and 
skin picking [18, 19]. Some authors have observed that 
many of these behavioural alterations are also present in 
autism spectrum disorders and that both the disorders 
may be associated with genetic alterations of chromo-
some 15 [20]. Forster and Gourash [21] have identified 
five domains related to behavioural alterations observed 
in patients with PWS: hyperphagia and related behaviour, 
hostility, rigidity of thought, skin picking and pathologi-
cal hoarding, feelings of insecurity with increased anxi-
ety. In a Japanese study, the authors have highlighted that 
patients with PWS often present anxiety disorder, obses-
sive compulsive disorder and mood instability in comor-
bidity [22].
Complications are almost all related to the underly-
ing endocrine alterations: osteoporosis with fractures, 
secondary hypogonadism disorders, sleep apnea, cardi-
ovascular disease, diabetes mellitus type 2 and all com-
plications related to the obesity that develops in almost 
all cases. Other complications are related to the frequent 
binges that can result in death due to self-suffocation, 
rupture of stomach and, in the case of ingestion of ined-
ible substances, poisoning. The behavioural alterations 
can further complicate the course of psychological devel-
opment and lead to a serious socio-environmental mal-
adjustment [23].
The only drug therapy indicated for this syndrome is 
growth hormone, which was approved in 2000 by the 
Food and Drug Administration (FDA) for the treatment 
of PWS in childhood [4]. This pharmacological treatment 
significantly reduces the initial muscular hypotonia and 
the subsequent risk for the development of obesity, par-
tially normalizes physical and psychological development 
and improves cognitive function. The prescription of 
this drug in adulthood is still debated due to the possible 
aggravation of diabetes and sleep apnea and the increased 
risk for edema and cancers [7, 11]. Many authors have 
identified multidisciplinary rehabilitative programs as 
indispensable tools to treat these patients [21, 24]. To 
support families and caregivers of these patients, many 
voluntary associations have been organized. In Italy, on 
12 July 1991, sixteen families living in Lombardy founded 
the first association for people with Prader Willi (www.
praderwilli.it) and, subsequently, other associations were 
founded [4].
Purpose
We describe the case of a male Patient suffering from 
PWS, treated in outpatient care by Mental Health Centre 
(MHC) and supported by Social Service since childhood, 
who was admitted to a residential rehabilitative facil-
ity (RRF), in April 2012. This RRF is dedicated to people 
with severe and very severe mental disabilities. After col-
lecting anamnestic information of the Patient from the 
medical records of out- and inpatient psychiatric ser-
vices and from the reports of parents and social assis-
tants respectively, we analysed the rehabilitative program 
developed for the Patient in the RRF as reported in the 
documentation and the clinical chart of this institute. In 
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order to assess the multi-professional clinical outcome of 
24-month rehabilitative program at the RRF, from April 
2012 to 2014, we evaluated, at the end of the observation 
period, the number of psychiatric admissions, hemato-
logic tests and body mass index (BMI), behavioural alter-
ations and functioning levels by administering symptom 
and functioning rating scales: the Italian scale, so called 
“VADO”: Valutazione di Abilità, Definizione di Obiettivi 
(evaluation of ability, definition of objectives) [25], Per-
sonal and Social Performance Scale (PSP) [26]. Finally, 
we report the current state of the Patient, updated in June 
2015, in order to better detail the outcome of his rehabili-
tation program.
Case presentation
Childhood
At the age of two, the Patient was abandoned by his par-
ents as were his brother and sister. Successively, he and 
his siblings were adopted by Italian parents. In the new 
family, our Patient lived in a detached country house 
with four of his adoptive brothers and two young chil-
dren, sons of two adoptive brothers, presenting good 
relationship with all components. Shortly, in early child-
hood, he presented severe hyperphagia and compulsive 
search for food and inedible substances, developing a 
sort of Pica. His adoptive mother referred that he was so 
attracted by substances with a good smell to eat scented 
soaps and drink bubble baths. Also, disgusting things 
such as rabbit faeces or rotten rubbish were stolen and 
eaten by him. When he was 3  years old, he was short 
but already weighed 33 kg. In the meantime, he progres-
sively developed aggressive behaviour, especially in case 
of prohibitions or restriction of food. At age 4, he was 
diagnosed with PWS by the methylation test in chromo-
somal region 15q11–13, which revealed the presence of 
a single methylated band, whose molecular evidence has 
been associated with the most common PWS pheno-
type. From that point onwards, his family implemented 
new restrictive rules, such as to lock the pantry or to lock 
him in his room during the night, in order to prevent the 
patient gaining weight or swallowing something inedible. 
Moreover, the patient’s family did not buy caloric food 
or scented substances and put in place many distracting 
activities for the Patient (watching movies, completing 
puzzles, etc.). His mother reported that, on more than 
one occasion, in order to prevent poisoning, the family 
consulted Emergency because the Patient had ingested 
leaves or other vegetable products with unknown effects. 
From kindergarten, his attendance at school was very 
problematic, despite the support of teachers dedicated 
to him, due to many behavioural alterations, learning 
difficulties, inability to maintain attention, aggressive-
ness, intolerance to frustration, lack of socialization skills 
and continuous search for food. He completed middle 
school, but, due to his problems, was rejected by more 
than one high school. Finally, he enrolled in a vocational 
school, where he attended only the first year, which he 
had to repeat, before dropping out. Despite his school 
failure, the Patient was able to cultivate some interests 
such as reading, drawing and composition of puzzles. 
In particular, he showed great skill in performing puz-
zles composed of many pieces. In addition, he was really 
interested in horror movies and comics, which could 
sometimes distract him from the compulsive search for 
food. When he was 17  years old, the Patient ran away 
from home, after being discovered by his parents in the 
act of eating a rotten cake collected from the garbage. 
Readily found by the Police, he claimed not to want to 
return to his family, complaining about abuses suffered 
in his family home (“My parents lock me in my room”). 
Therefore, the local Social Service for Minors, promptly 
activated, provided for the temporary placement of the 
Patient in a community. In the meantime, the Patient was 
admitted to the psychiatric day hospital of an accred-
ited private hospital dedicated to adolescent psychiatric 
patients, in order to evaluate his psychological profile 
(interpersonal skills, reaction to stress and tolerance for 
frustration) and assess, in the meantime, the ability of the 
family to adequately support him.
The first psychiatric hospitalization
After about 20 days of staying in community, our Patient 
presented such a dangerous aggressive behaviour against 
another boy who lived in the community, as to be hos-
pitalized in a psychiatric ward. He was discharged after 
a few days, and sent to the psychiatric ward dedicated 
to adolescent patients in a private hospital, where he 
remained hospitalized for about 3  months. During this 
hospitalization, many clinical features of PWS emerged, 
in particular hyperphagia and severe behavioural altera-
tions, characterized by outbursts of anger and violence 
toward objects and people. WAIS was administered to 
him, where he obtained a score of 68 on verbal IQ scale 
and 62 on performance IQ scale On the Vineland scale, 
the patient showed a result consistent with mild mental 
impairment.
The first rehabilitative program
At discharge from the private psychiatric hospital, he 
was sent back to his adoptive family with a rehabilita-
tion program, which provided for daily attendance at the 
rehabilitative centre of a mental disability facility. Clinical 
conditions of the Patient remained stable for 5  months. 
Afterwards, he was again hospitalized in the public acute 
psychiatric ward due to agitation and aggressiveness, 
apparently motivated by frustration for being scolded by 
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both professionals and parents for his “sentimental effu-
sion” towards a female patient who attended the same 
rehabilitative centre. After few days, he was discharged 
and sent to the adult outpatient psychiatric services since 
he had come of age.
The long psychiatric hospitalization
A few days after previous hospitalization, he was re-admit-
ted to the same acute psychiatric ward, due to an outburst 
crisis at the rehabilitative centre, reactive to the attempts of 
professionals to control his dangerous abuse of water. He 
binged daily on water, especially at lunch time, in response 
to rigid reduction of food intake. During this hospitaliza-
tion, the Patient presented dangerous behaviour: abuse 
of water, theft of food from other patients (also leftovers 
from dishes or rubbish bins) and theft of money to buy 
food. In particular, he remained awake at night to go hunt-
ing for food and money in the rooms of other patients. 
The Patient also used to hoard stolen food in some hiding 
places on the ward (including in the toilet bowl), where he 
went to eat food unseen. When he was discovered com-
mitting these acts as well as when he was prohibited eat-
ing more than his regulated diet, he became extremely 
aggressive with explosive and unstoppable violence against 
people and objects surrounding him. It was necessary to 
pharmacologically and physically restrain him repeat-
edly. During this long hospitalization, mother, who, in the 
meantime, was nominated his legal guardian, referred not 
to be available to take him home again due to his danger-
ous behaviour, which she and her husband were not able 
to contain. She asked to place the Patient in a rehabilitative 
facility in order to modify his behaviour. After a month 
of hospitalization, the Patient presented aggressiveness 
frequently difficult to contain as well as uncontrollable 
food intake (he had gained about 10 kg since admission), 
although he continued his daily rehabilitative activities 
in an outpatient service. Therefore, a multi-professional 
meeting planned to transfer the Patient to a residential 
rehabilitative facility (RRF) for people with disabilities, and 
to dedicate professionals to him 24 h a day, at least in the 
beginning of the program.
Rehabilitation in the residential facility
At admission to the RFF, a complex and intensive pro-
gram which provided maximum control over food intake 
and, at the same time, various physical activities and rec-
reations, was tailored for the Patient.
A. Control of food intake. A low-fat diet with MCT 
(medium-chain triglyceride) of 1700  kcal/day, 
divided into three main meals and two snacks, one 
in the morning and one in the afternoon, was pro-
vided; the Patient was not allowed to consume morn-
ing and afternoon snacks with other patients, hav-
ing a dietary restriction that others did not have and 
other many prohibitions related to food were estab-
lished (no access to the kitchen pantry day or night, 
no change to the timing of meals in order to main-
tain regular life habits, no using food as bargain or 
as reward or punishment in order to reduce positive 
reinforcement by food).
B. Motor activities. An intensive program was car-
ried out, under the constant supervision of educa-
tors, which included physical activities and games: 
gymnastics with a frequency of four times a week at 
the RRF gym, soccer play with the other guests and 
swimming in the pool once a week; physical activ-
ity under teacher supervision at a gym once a week. 
During the rest of the time, the Patient was encour-
aged to walk as much as possible by the operator 
dedicated to him in order to counteract the tendency 
to weight gain and, at the same time, to distract him 
from the compulsive search for food.
C. Activities aimed at improving socialization and 
autonomy capacity. Many organized recreational 
activities were planned: visits to farms, libraries, play-
grounds, leisure centres, etc., together with other 
patients who lived in the RRF and with profession-
als dedicated to him. Regarding money management, 
educators received money from Patient’s mother, his 
legal guardian, and delivered money to him, accord-
ing to some clear rules: he could receive a certain 
sum to buy only one item during the weekly recrea-
tional walk (food purchase was not allowed). In this 
regard, the Patient had to previously agree with the 
educator on the item to buy, through a written agree-
ment signed by both parties, and could not change 
his choice.
During his stay at the residential facility, the patient 
also continued to be seen regularly by his referring 
psychiatrist. In these meetings, the Patient revealed 
his feelings of inadequacy, anxiety, anger and fears. He 
complained to be suffering due to “the insatiable desire 
for food” and “attraction towards girls”. All visits ended 
with the same incessant requests to be admitted to the 
public psychiatric hospital, where the patient felt “less 
controlled”. A new psychotherapy for the Patient was 
carried out by a psychologist from the Prader-Willi 
Association, focusing on the Patient’s feelings of aban-
donment by his adoptive mother and his difficulties 
with others. The Patient was also monitored monthly by 
the general physician of the RRF, who regularly checked 
his physical condition (body weight, hematic tests). 
He was periodically visited by endocrine and nutrition 
specialists.
Page 5 of 9Di Lorenzo et al. BMC Res Notes  (2016) 9:199 
The assessment of outcomes
The number of psychiatric hospitalizations during the 
observation period
After 3 months, the Patient was again admitted to the public 
psychiatric hospital because of his hostile and threatening 
behaviour. After his admission, he immediately appeared 
sufficiently quiet and cooperative as to be promptly dis-
charged and sent back to the RRF in order to continue 
his program. After another 6 months, he presented a new 
crisis for the “loss” of his adoptive family requiring com-
pulsory psychiatric hospitalization, due to uncontrollable 
outbursts of anger and violence. After 7  days, he was dis-
charged to resume his rehabilitative program. Successively, 
in concomitance with the summer holidays of his referring 
professionals, momently substituted by other ones, and the 
reduction of his recreational activities, he presented a pro-
gressive increase of dangerous behaviour. In that period, he 
had physically assaulted a professional, causing him an arm 
fracture; he had removed the cannula for parenteral nutri-
tion from the body of another patient, in a vain attempt to 
feed by it; he had repeatedly ingested earth and grass gath-
ered from the garden of the institute and so on. Finally, the 
Patient was admitted again to the public psychiatric ward, 
where he presented violence against himself, motivated 
by the frustration of not being able to eat freely despite his 
insatiable hunger. In the ward, he was isolated from other 
patients and controlled 24 h a day by one of the professionals 
dedicated to him. This intensive control permitted his rapid 
tranquillization and, consequently, his discharge after few 
days. He was again sent to the RRF, where he continued his 
program with new activities: he began a protected work pro-
ject in an outside rehabilitative centre for 2 h once a week. 
At this centre, the Patient performed small manual tasks 
such as assembling and packaging items, under the constant 
supervision of his professionals, and earned a monthly sal-
ary. In the meantime, his adoptive mother reduced her visits 
to him to no more than once a month hoping to reduce the 
patient’s tantrums, whereas his biological sister, who lived 
in the same adoptive family, progressively increased her vis-
its, accompanying him out for walks and home visits. The 
Patient, who looked forward to going back to his family, pre-
sented appropriate behaviour during his monthly author-
ized home visit, reporting great satisfaction. Successively, he 
was not hospitalized, showing a progressive improvement in 
his behaviour with good adaptation to the RRF. As shown in 
Fig. 1, the days of hospitalizations were significantly reduced 
to zero at the end of the observation period, fulfilling one of 
the main outcomes of his rehabilitation program.
Pharmacological therapies
The patient was treated with neuroleptics and benzodiaz-
epines due to his severe behavioural alterations, despite 
the risk for increased appetite. At the initial admission 
to the RRF, he was treated with 30  mg of aripiprazole 
and 1500 mg of valproic acid, but after a few weeks, val-
proic acid was suspended due to its inefficacy to con-
trol aggressiveness. During the observation period, the 
patient frequently required additional sedative therapies 
for his severe behavioural alterations, like chlorpromazine 
(100  mg/day) and benzodiazepines (alprazolam 3.5  mg/
day, clordemetildiazepam 2mg/day, lorazepam 4 mg/day). 
The patient had never been prescribed hormonal therapy 
(growth hormone or testosterone), which was not consid-
ered useful by endocrinologists who examined him, given 
the risk of worsening his behavioural problems.
The scale scores
“VADO”: (a) Specific outcome (Fig.  2), which consisted 
of avoiding psychiatric hospitalizations, pathologically 
required by the Patient, was achieved an improvement 
rate of 63 %; (b) Rehabilitation Areas (Fig. 3), which eval-
uated the Patient’s adherence to different rehabilitation 
activities, showed an improvement rate of 51 %; (c) Per-
sonal and Social Performances (Fig. 4), which evaluated 
the Patient’s ability to take care of his personal hygiene 
and clothing, showed an improvement of 61 %.  
“Personal and Social Performance Scale” (PSP) 
reported an overall improvement of 44  % at the end of 
the observation period, with the highest percentage of 
improvement (60  %) in his disturbing and aggressive 
behaviour (Fig. 5).
Body mass index (BMI)
At the initial admission to the RRF, the patient presented 
a BMI of 33.9 (weight 90  kg, height of 1.63  cm), higher 
than the normal value of 24.9. At the end of the observa-
tion period, he had a BMI of 32.8, despite the strictly con-
trolled diet and regular physical activity (Fig. 6).
During all internist visits, any significant organic 
complications were registered; in particular any sign of 
75 
45 
4 
0 
2011 2012 2013 2014
 Hospitalization days
Fig. 1 Days of psychiatric hospitalizations during the observation 
period
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hypothyroidism or diabetes mellitus was noted. All his 
hematic tests were mostly normal.
Current state update
To date, the patient continues his rehabilitation activities 
at the RRF, with good cooperation despite some moments 
of anger and aggression that his professionals are able to 
contain without resorting to psychiatric hospitalization. 
He follows his usual hypocaloric diet with no extras and, 
at the last control, he weighed 87 kg (BMI = 32.74) with 
normal hematic test. Ultimately, he shows an increased 
interest in hoarding different non-food items such as toy 
soldiers, comics, horror movies, crossword puzzles, etc., 
all activities which are allowed in the RRF, suggesting that 
he maintains compulsive behaviour although directed on 
different objects from food.
Conclusion
In our PWS case, psychiatric intervention was necessary 
because of his severe mental and behavioural alterations: 
aggressiveness, mental retardation, outbursts of anger, 
disruptive crisis, obsessive and compulsive behaviour. 
These symptoms, related to the genetic disorder, had 
probably been exacerbated by early abandonment by his 
biological parents and, successively, by the difficulty his 
adoptive family had in caring him. In line with most stud-
ies [2, 27, 28], our case shows that a genetic syndrome 
can impair individual’s essential needs, leading to severe 
maladjustment. This condition requires a bio-psycho-
social approach in order to take care of both organic con-
ditions and psychological needs without neglecting the 
environmental conditions.
The psychiatric intervention was closely connected 
with well-structured rehabilitation programs at the 
RFF, which stimulated Patient’s capabilities, despite his 
initial poor self-management skills, and, in the mean-
time, controlled his behaviour by the regular daily pres-
ence of one of the three professionals dedicated to him. 
This continuous and intense rehabilitation program 
has led to a significant reduction of hospitalizations, 
allowing the Patient to avoid the behavioural regres-
sion induced by frequent and recurrent admissions, 
at the cost of an increased dependence on institu-
tions. Despite these positive results, the weight control 
induced only a slight reduction in BMI, maintaining it 
within the range of moderate obesity at the end of the 
observation period. Nevertheless, this result obtained 
through an enormous rehabilitative and educational 
effort by the RRF staff, represented a good outcome 
since further weight gain, which is the common final 
pathway in most PWS, was avoided. The data show that 
obesity related to genetically induced hyperphagia can 
be controlled by a regular and long-term rehabilita-
tive approach tailored to behavioural and psychological 
alterations. At the RRF, body weight control was car-
ried out 24  h a day through the adoption of different 
strategies aimed at controlling of food intake and, in 
the meantime, at reinforcing all activities without any 
oral gratification. At the end of the observation period, 
the staff registered a significant improvement in the 
rehabilitation areas of his personal and social func-
tioning, whereas his referring psychiatrist found most 
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relevant the reduction of his disturbing and aggressive 
behaviour.
Finally, the clinical observation of this case leads us to 
compare PWS to drug addiction and indirectly endorse 
the neurophysiological hypothesis that food and drugs 
stimulate the same brain circuits in the limbic system 
[15]. In this regard, many symptoms presented by our 
Patient, such as impulsivity, craving for food, compulsive 
overeating and obesity support the concept of food addic-
tion, first developed by Gold’s team [29] and successively 
interpreted as a Reward Deficiency Syndrome by other 
authors [30], suggesting a commonality between sub-
stance and behavioural addiction. Food addiction, which 
shares with substance abuse and gambling DSM-5 criteria 
and brain reward networks, is characterized by craving, 
as well as other addictions, which, in this case, is for food 
[31]. Other studies have shown that obese populations 
with greater BMI present changes in reward pathways 
similar to those observed in drug addiction. In particu-
lar, some research has found that, in individuals with 
higher BMI, dopaminergic receptors are down-regulated 
[32] and present greater activation in the gustatory cor-
tex and somatosensory brain regions in the presence of 
food [33]. Other genetic studies have confirmed biological 
predisposition to overeating and weight gain, indicating 
that genetic polymorphism of dopamine D2 receptor and 
leptin receptor genes are involved in obesity and craving 
for food [34, 35]. PWS could represent an extreme case 
biologically conditioned, which could help us to better 
understand the complex pathophysiological mechanisms 
that underlie both addiction and obesity. Most studies 
underline that effective treatments for drug addiction 
and obesity can be different since the modality of relapse 
is not similar [36]. Some authors have indicated that a 
pharmacological strategy aimed at improving dopamine 
functioning could be effective for both diseases, but, up 
to now, the results are inconclusive. Nevertheless, due 
to the complexity of addiction and obesity, which can be 
strongly influenced by environmental factors, behavioural 
therapeutic programs aimed at improving the capacity of 
the individual to control on his/her compulsive behaviour 
by means of positive reinforces can be effective.
Our clinical case, emblematic for its complex thera-
peutic and rehabilitative needs, required a multidis-
ciplinary staff since many different activities, ranging 
from control of organic symptoms to educational and 
rehabilitation programs, were necessary to manage his 
multiple symptoms. Nevertheless, an empathic relation-
ship, despite Patient’s manipulative and aggressive atti-
tudes, was necessary to motivate and support him in the 
course of such a difficult treatment. Although the genetic 
component heavily influenced the course of this disor-
der, we can highlight that a long-term, well-defined and 
individualized rehabilitative program can control patho-
logical behaviour, including hyperphagia, and therefore 
improve the long-term prognosis. In order to implement 
these programs, emphatic therapeutic relationships are 
necessary in order to support and motivate patients in 
adhering to rehabilitative programs, the only available 
treatment preventing potential regressive evolution.
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